FDA Eliminates REMS Barriers to Boost CAR-T Therapy Access
FDA Eliminates REMS Barriers to Boost CAR-T Therapy Access
The FDA removed REMS requirements for approved CAR-T therapies, easing access, reducing monitoring, and shortening patient proximity and driving restrictions. This aims to increase uptake, especially in rural areas, and reduce burdens on healthcare providers and patients.
